<?xml version="1.0" encoding="UTF-8"?>
<p>We report the safety and efficacy results of single oral dose baloxavir treatment in otherwise healthy children 1â€“&lt;12 years old with acute influenza from miniSTONE-2 (
 <ext-link ext-link-type="uri" xlink:href="http://Clinicaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">Clinicaltrials.gov</ext-link> identifier: NCT03629184), a phase III, randomized, active controlled trial.
</p>
